Destiny Hinton

St. Jude Children’s Research Hospital is launching the largest strategic investment in its nearly 60-year history, committing $11.5 billion during the next six years to accelerate research and treatment globally for children with catastrophic diseases.

Cancer treatments can result in damage to the heart both during treatment and years following completion of therapy. As many cancer survivors are now living longer into adulthood, we’re gaining a better understanding of some of the late effects of cancer treatments that we weren’t able to observe before.

Scientists are learning more about antibody production in response to flu, including how they develop from helper T cells and monocytes.

The pandemic exposed shortcomings in health care. But this study revealed more than expected in this type of children’s treatment.

Tangie Thomas, MPH, is vice president of Clinical Trials Operations at St. Jude Children’s Research Hospital.

For Jasmine Turner, resilience and tenacity were required to enter a field with very few Black women. There weren’t many women or teachers of color in her scientific courses—no one with similar experiences to help guide her or focus her talents. She turned to her mother for encouragement and inspiration.

This study, to our knowledge, is the first to objectively measure hearing and neurocognitive function in a large cohort of long-term survivors of childhood cancer stratified by treatment exposures.

Andrea Stubbs shares her experiences that shaped her career in community outreach to raise awareness for both HIV and HPV.

Women of St. Jude highlights the influences and events that shaped the career of Pat Keel, who shares lessons she’s learned about teamwork and leadership.

Survival and quality of life for many with sickle cell disease depends upon where they live. Here’s what a doctor wants to do to fix that.